GlaxoSmithKline Pharmaceuticals Share Price
₹2,275.95 -50.35 (-2.16%)
21 Dec, 2024 21:54
Start SIP in GLAXO
Start SIPPerformance
- Low
- ₹2,264
- High
- ₹2,326
- 52 Week Low
- ₹1,668
- 52 Week High
- ₹3,088
- Open Price₹2,325
- Previous Close₹2,326
- Volume85,491
Investment Returns
- Over 1 Month -6.65%
- Over 3 Month -16.22%
- Over 6 Month -10.04%
- Over 1 Year + 34.88%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 57.1
- PEG Ratio
- 13.6
- Market Cap Cr
- 38,556
- P/B Ratio
- 21.7
- Average True Range
- 65.32
- EPS
- 47.33
- Dividend Yield
- 1.9
- MACD Signal
- -64.41
- RSI
- 37.24
- MFI
- 39.62
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,275.95
-50.35
(-2.16%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹2,354.03
- 50 Day
- ₹2,466.65
- 100 Day
- ₹2,524.06
- 200 Day
- ₹2,428.53
Resistance and Support
2288.75
- R3 2,375.80
- R2 2,351.05
- R1 2,313.50
- S1 2,251.20
- S2 2,226.45
- S3 2,188.90
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,275 As on 21 December, 2024 | 21:40
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹38556 Cr As on 21 December, 2024 | 21:40
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 57.1 As on 21 December, 2024 | 21:40
The PB ratio of GlaxoSmithKline Pharmaceuticals is 21.7 As on 21 December, 2024 | 21:40
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.